Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Abstract The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the…
Carmen Guaza
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
Abstract Background: Multiple sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes variously dominant in different stages…
A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
Abstract Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases.…